secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2023-01-24T23:59:59+00:00
Accession:  0001213900-23-004881
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics receives Nasdaq deficiency notice for minimum bid price non-compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on Jan 19, 2023 for failure to meet $1.00 minimum bid price rule (Nasdaq 5550(a)(2)).
- Company has 180 calendar days, until July 18, 2023, to regain compliance; stock must close at $1.00+ for 10 consecutive days.
- If not cured, may request additional 180 days if meeting other listing requirements and intending reverse stock split.
- Failure to regain compliance could lead to delisting; company is considering options to cure deficiency.
- Receipt of notice does not affect business operations or SEC reporting requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023004881/0001213900-23-004881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023004881/ea172094-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-004881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer